Drug recall · March 13, 2019
Drospirenone and Ethinyl Estradiol Tablets recall
Why: Contraceptive Tablets Out of Sequence: Missing or incorrect tablet placement.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/0.03 mg, 28 Tablets Blister, 1 Unit (NDC 60505-4183-1) packaged as 84 Tablets Blister, 3x1 Unit per carton (NDC 60505-4183-3), Rx Only, Manufactured for: Apotex Corp., Weston, FL 33326; Manufactured by: Oman Pharmaceutical Products Co. L.L.C., P.O. Box 1885, Postal Code 111, Seeb.
- Lots / codes
Lots: 7DY008A, 7DY009A, 7DY010A, 7DY011A, Exp. 08/2020
- Quantity
- 82,705 cartons
- Company
- Apotex Inc., North York, N/A
- Distribution
- Nationwide in the USA.
- Initiated
- March 1, 2019 · Voluntary: Firm initiated
- Classified
- March 11, 2019
- Reported
- March 13, 2019
- How notified
- Press Release
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Estradiol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.